JP Patent

JP2010159272A — ５−ｈｔ１ｆアゴニストとしてのピリジノイルピペリジン

Assigned to Eli Lilly and Co · Expires 2010-07-22 · 16y expired

What this patent protects

【課題】ピリジノイルピペリジンの製造方法の提供。【解決手段】式(ＩＩＩ)：または式(Ｖ)：で示される化合物の製造方法。【選択図】なし

USPTO Abstract

【課題】ピリジノイルピペリジンの製造方法の提供。【解決手段】式(ＩＩＩ)：または式(Ｖ)：で示される化合物の製造方法。【選択図】なし

Drugs covered by this patent

lasmiditan-succinate (LASMIDITAN SUCCINATE)

Patent Metadata

Patent number: JP2010159272A
Jurisdiction: JP
Classification: —
Expires: 2010-07-22
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.